Led by Dr. Carlos Gonzalez and developed at the CPT through partnership with Otsuka Pharmaceutical since 2010, the world-first phage product for Pierce’s disease in grapevines is now officially marketed in the U.S. after two seasons of successful use. This effort is featured in AgriLife Today.
Center for Phage Technology: Home / In the News / Official launch of the CPT supported phage product